Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Evidence-based therapeutic drug monitoring for indinavir].
Barrail-Tran A, Taburet AM, Poirier JM; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Barrail-Tran A, et al. Among authors: poirier jm. Therapie. 2011 May-Jun;66(3):239-46. doi: 10.2515/therapie/2011035. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819808 Review. French.
[Evidence-based therapeutic drug monitoring of lopinavir].
Barrail-Tran A, Taburet AM, Poirier JM; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Barrail-Tran A, et al. Among authors: poirier jm. Therapie. 2011 May-Jun;66(3):231-8. doi: 10.2515/therapie/2011034. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819807 Review. French.
Niveau de preuve du suivi thérapeutique pharmacologique du lopinavir.
Barrail-Tran A, Taburet AM, Poirier JM; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Barrail-Tran A, et al. Among authors: poirier jm. Therapie. 2011 May-Jun;66(3):231-8. doi: 10.2515/therapie/2011034. Therapie. 2011. PMID: 27393203 French.
Niveau de preuve du suivi thérapeutique pharmacologique de l'indinavir.
Barrail-Tran A, Taburet AM, Poirier JM; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Barrail-Tran A, et al. Among authors: poirier jm. Therapie. 2011 May-Jun;66(3):239-46. doi: 10.2515/therapie/2011035. Therapie. 2011. PMID: 27393204 French.
Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Poirier JM, Robidou P, Jaillon P. Poirier JM, et al. Ther Drug Monit. 2005 Apr;27(2):186-92. doi: 10.1097/01.ftd.0000152680.36517.5d. Ther Drug Monit. 2005. PMID: 15795650
High variability of plasma drug concentrations in dual protease inhibitor regimens.
Guiard-Schmid JB, Poirier JM, Meynard JL, Bonnard P, Gbadoe AH, Amiel C, Calligaris F, Abraham B, Pialoux G, Girard PM, Jaillon P, Rozenbaum W. Guiard-Schmid JB, et al. Among authors: poirier jm. Antimicrob Agents Chemother. 2003 Mar;47(3):986-90. doi: 10.1128/AAC.47.3.986-990.2003. Antimicrob Agents Chemother. 2003. PMID: 12604531 Free PMC article.
Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
Poirier JM, Robidou P, Jaillon P. Poirier JM, et al. Ther Drug Monit. 2002 Apr;24(2):302-9. doi: 10.1097/00007691-200204000-00012. Ther Drug Monit. 2002. PMID: 11897976
106 results